Introduction

Fetal valproate syndrome is described as a condition occurring in children exposed to valproate (valproic acid) during pregnancy. Valproate is a drug, often prescribed to patients for bipolar disorders, epilepsy and migraine, which, when consumed by mothers during the first trimester, can lead to neurodevelopmental difficulties in the infants (Tomson et al., 2018). The symptoms are observed as significant facial features like a broad forehead and thin upper lip, cognitive disabilities, and night, and even have congenital abnormalities. These children also have a higher risk of autism spectrum disorder (ASD), including intellectual disabilities (Rasalam et al., 2005). Studies have suggested that the prevalence of FVS is about 10-40% in children exposed to valproate in utero, therefore making it important to create awareness and the need for preventive measures (Bromley et al., 2013).

Importance of speech and language development

Speech and language development is crucial for kids' general cognitive and social development, further essential to reach academic success, daily social interaction, and effective communication with others (Paul & Norbury, 2012). Delayed development of speech and language can be marked as early indicators of serious developmental issues, such as FVS. To prevent the severity of symptoms and a suitable therapeutic approach, early diagnosis of speech and language impairments is important (Law et al., 2000). To design individualised treatment approaches, it is imperative to understand the impact of FVS on speech and language development, given its association with social and cognitive challenges.

Valproate and its impact on fetal development

Mechanism of action of valproate

Since valproate, often referred to as valproic acid, has a broad spectrum of action, it is frequently prescribed as an antiepileptic medication. Gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that aids in stabilising neuronal activity and preventing seizures, is the main way that it functions in the brain (Perucca, 2002). Furthermore, valproate decreases excessive neuronal activity by blocking sodium and calcium channels, which is important for managing epilepsy (Rogawski & Löscher, 2004). Despite being effective in treating seizures, studies have indicated that valproate may have significant teratogenic effects, particularly if given during the first trimester of pregnancy. According to Tomson et al. (2011), the drug can cross the placental barrier and expose the developing fetus to its possibly harmful effects.

Key features of fetal valproate syndrome (FVS)

The physical and neurological anomalies that define Foetal Valproate Syndrome (FVS) are unique. A large forehead, epicanthal folds, a flat nasal bridge, and a thin upper lip are among the physical dysmorphisms that children with FVS frequently display. According to Moore et al. (2000), these characteristics, despite their subtlety, are frequently present in all instances and can help with the clinical diagnosis of the illness. Children exposed to valproate in utero are more likely to have facial abnormalities as well as congenital malformations such as neural tube defects (like spina bifida), congenital heart defects, and limb abnormalities (Bromley et al., 2013). FVS is linked to neurodevelopmental consequences that can be concerning. With many displaying cognitive deficits that impact memory and learning, children with FVS are more likely to develop intellectual disabilities. Furthermore, studies suggest that up to 30–40% of exposed children may receive an autism spectrum disorder (ASD) diagnosis. Prenatal valproate exposure is also linked to an elevated risk of ASD (Bromley et al., 2013; Christensen et al., 2013). These neurodevelopmental problems further complicate the lives of impacted individuals and their families by frequently presenting as behavioural problems, difficulties interacting socially, and delays in speech and language development.

Speech and language development in FVS

Typical speech and language milestones

Speech and language abilities develop in children who are generally developing through predetermined stages. According to Paul and Norbury (2012), newborns often start uttering words by the time they are 12 months old, and by the time they are 18 to 24 months old, they can form rudimentary statements using words. Most kids can compose entire phrases by the time they are three years old, and their vocabulary grows quickly. The development of cognition, social interaction, and subsequent academic performance all depend on these early linguistic abilities. Early monitoring is crucial since delays in meeting these milestones may be early signs of underlying developmental problems (Rescorla, 2009).

Delays and disorders in FVS

Children diagnosed with FVS are seen to showcase speech and language abnormalities. Studies have suggested that these children suffer with both expressive and receptive skills, resulting in social difficulties, slower vocabulary control, difficulty in sentence formation and comprehending basic language (Bromley et al., 2013). Along with speech learning, speed production and articulation difficulties are also observed in FVS. Inability to produce sounds, phonological processing delays, and all of these affect their capacity to understand the sounds in general. (Williams et al., 2010).

Therefore, children with FVS experience delayed speech and language development in comparison to their peers. For example, it may take longer than 12 months to say their first word (Laje et al., 2013).

Contributing factors

There are several factors causing language deficits in FVS patients. The primary factor is a neurodevelopmental disorder exhibiting cognitive impairments, further leading to decreased intellect and improper functioning (Meador et al., 2013). FVS combined with attention deficit disorders, observed in most FVS patients, can also cause struggling concentration on speech learning tasks and impact social interactions (Cummings et al., 2011).

Apart from cognitive factors, social interactions and the environment also play a vital role. With fewer opportunities for interactions due to their setbacks from language difficulties, their exposure to conversations and practising vocabulary decreases. Parents and caregivers need to practice effective strategies to build communication with their children to reduce the effects of language difficulties (Sood et al., 2015). 

Intervention strategies

Tailored therapeutic approaches

For children with FVS, the therapy needs to be strategised for their unique challenges with speech and language deficits.  Therapy generally focuses on articulation disorders and difficulties in producing phonological sounds and specifically improving these areas (Williams et al., 2010). These therapeutic interventions include speech, physical exercises to improve speech, vocabulary learning, clarity of sound produced and sentence formation. The best ways to achieve this are through interactive play, repetition of activities, and visual aids (Cummings et al., 2011).

Therapists work with families as a unit to establish a socially stimulating environment in their homes. Reading aloud, routine verbal conversations are the training skills developed in parents to enhance the progress in children, building a home environment. Research has demonstrated that the active involvement of parents enhances the effectiveness of therapeutic approaches intended to yield positive results (Sood et al., 2015; Law et al., 2004).

Long-term management

Long-term improvement in vocal modulation and language acquisition among children with FVS can be ensured by consistent care and ongoing monitoring. According to Paul and Norbury, ongoing evaluation is crucial for monitoring advancements, recognising new difficulties, and guaranteeing the efficacy of therapies. With the help of feedback from parents and educators as well as frequent evaluations by speech-language pathologists, therapy plans are modified in accordance with a comprehensive understanding of the child's development. In addition to speech and language abnormalities, children diagnosed with FVS often have behavioural and cognitive problems, such as learning challenges and attention deficits (Meador et al., 2013).

Behavioural strategies can be used to increase focus and engagement in speech therapy sessions, and educational support can be tailored to the language and learning needs of the classroom (Cummings et al., 2011). In general, managing speech and language development in FVS is a dynamic process that necessitates adaptability, ongoing assessment, and cooperation between families and professionals.

Summary

In summary, speech and language development, which are vital for successful cognitive, social, and academic functioning, are especially difficult for individuals with foetal valve syndrome (FVS). Significant physical and neurological abnormalities result from the teratogenic effects of valproate during pregnancy, with notable delays in speech and language milestones being prevalent. Personalised treatment strategies, such as speech-language pathology and active parental and carer participation, are critical to overcoming these obstacles. To modify interventions as the child's requirements change, long-term care that incorporates ongoing assessment and a multidisciplinary approach is essential. Enhancing communicative abilities and general quality of life for kids with FVS can be achieved through a combination of focused therapy and nurturing surroundings, underscoring the significance of prompt and ongoing assistance.

FAQs

How does valproate cause FVS?

Valproate is a drug administered to women with epilepsy, migraines or bipolar disorders. This drug has the tendency to cross the placenta during pregnancy, resulting in interference with fetal development. Its teratogenic effects can be the result of disruptions in folate metabolism, oxidative stress pathways, and inhibition of histone deacetylase, causing various congenital and neurodevelopmental abnormalities.

What are the common physical features of FVS?

The most common features seen in children with FVS are facial dysmorphisms, such as a broad forehead, flat nasal bridge, thin upper lip, and epicanthal folds. Congenital malformations such as neural tube anomalies, congenital heart defects, and limb abnormalities are among the other prevalent physical traits.

Can FVS be prevented?

Avoiding the use of valproate during pregnancy can dramatically lower the risk of FVS. When considering other medications or preventive measures in case of pregnancy, women who are of reproductive age and using valproate for epilepsy or other illnesses should speak with their healthcare professional.

What should parents do if they suspect their child has FVS?

A healthcare expert, such as a paediatrician or geneticist, who can evaluate the child's development and provide a diagnosis, should be consulted if parents think their child may have FVS. Then, to address developmental delays, early intervention programs, like speech-language therapy, can be started.